SpringWorks Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
SpringWorks Therapeutics (Nasdaq: SWTX) announced that CEO Saqib Islam will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 8:15 am ET. A video webcast of the event will be available on the company's Investors & Media section of their website, with a replay accessible afterward. SpringWorks focuses on developing medicines for severe rare diseases and cancer, with 17 development programs in progress, including two late-stage clinical trials.
- None.
- None.
STAMFORD, Conn., Jan. 04, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 am ET.
A video webcast will be available on the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the conference.
About SpringWorks Therapeutics
SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for patients living with severe rare diseases and cancer. SpringWorks has a differentiated targeted oncology portfolio of small molecule product candidates and is advancing 17 development programs, including two potentially registrational clinical trials in rare tumor types as well as several programs addressing highly prevalent, genetically defined cancers. SpringWorks’ strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with innovators in industry and academia to expand its portfolio and create more solutions for patients with cancer. For more information, visit http://www.springworkstx.com and follow @SpringWorksTx on Twitter and LinkedIn.
SpringWorks Contacts:
Kim Diamond
Vice President, Communications and Investor Relations
Phone: 203-561-1646
Email: kdiamond@springworkstx.com
Samantha Hilson Sandler
Director, Investor Relations
Phone: 203-461-5501
Email: samantha.sandler@springworkstx.com
FAQ
When will SpringWorks Therapeutics present at the J.P. Morgan Healthcare Conference?
Where can I watch the SpringWorks Therapeutics conference presentation?
What is the focus of SpringWorks Therapeutics?
How many development programs does SpringWorks Therapeutics have?
What is the stock symbol for SpringWorks Therapeutics?
